This outcome was confirmed by repeat phototesting in a subgroup. In only 5 patients, an improvement of cutaneous LE symptoms was noted by either physician or patient. No serious adverse events were encountered.
This outcome was confirmed by repeat phototesting in asubgroup. In only 5 patients, an improvement of cutaneous LE symptoms was noted by either physician orpatient. No serious adverse events were encountered.